NCT00103285 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE3
NCT00101101 Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00101010 Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00098839 Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE1/PHASE2
NCT00096382 Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00096135 Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes Status COMPLETED Phase NA
NCT00095862 Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers Status TERMINATED Phase PHASE1/PHASE2
NCT00094380 Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) Status COMPLETED Phase PHASE1/PHASE2
NCT00093834 Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer Status COMPLETED Phase PHASE1
NCT00093795 Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Status COMPLETED Phase PHASE3
NCT00093587 Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Status UNKNOWN Phase NA
NCT00092222 Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00091611 Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer Status TERMINATED Phase PHASE1
NCT00091104 Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma Status COMPLETED Phase PHASE1
NCT00090051 FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients Status COMPLETED Phase PHASE3
NCT00089726 A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00089453 Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant Status COMPLETED Phase PHASE1
NCT00088881 Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE2
NCT00087178 Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer Status COMPLETED Phase PHASE3
NCT00085735 Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Status COMPLETED Phase PHASE3